Identity
- Type
- university
- Country label
- USA
- HQ country
- USA
- Founding country
- not in the notes
- Parent
- not in the notes
- Parent country
- not in the notes
- Country basis
- the research notes
Where this comes from
Convention D1: a dual label, HQ first, when the HQ, founding or parent country differ.
Models by Class
Models
ModelClassOpennessParametersReleased
Links
Organisation
MIT (Jameel Clinic)university, USA
Models
Boltz-2Boltz PBC, scientific
Boltz-1Boltz PBC, scientific
MeloTTSMyShell.ai, speech synthesis
OpenVoiceMyShell.ai, speech synthesis+1 more
Who Runs It
PfizerContract signed, 8 Jan 2026
PfizerContract signed, 8 Jan 2026Models 5
Scores
| Benchmark | Model | Score | Who ran it | Setting |
|---|---|---|---|---|
| FEP+/OpenFE binding affinity benchmark | Boltz-2 | 0.62 Pearson r | vendor-reported | About 0.62; about 1,000x faster than FEP |
Where this comes from
Every recorded score of this organisation's models, with who ran it. Scores from different settings are not directly comparable.
Sources
- Open source protein models: OpenFold vs Boltz scalingbiotech.substack.com https://scalingbiotech.substack.com/p/open-source-protein-models-openfold
- Our Vision: The Future We Are Building at Boltz boltz.bio https://boltz.bio/manifesto
To cite this page: Project AURION, AI Use-Cases Research & Innovation, "MIT (Jameel Clinic)", https://aurion.semai.id/organisations/mit/, records of October 2026.